These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34694178)

  • 21. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
    de Sola S; Tarancón T; Peña-Casanova J; Espadaler JM; Langohr K; Poudevida S; Farré M; Verdejo-García A; de la Torre R
    Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerobic Fitness Level Moderates the Association Between Cannabis Use and Executive Functioning and Psychomotor Speed Following Abstinence in Adolescents and Young Adults.
    Wade NE; Wallace AL; Swartz AM; Lisdahl KM
    J Int Neuropsychol Soc; 2019 Feb; 25(2):134-145. PubMed ID: 30474579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study.
    Tervo-Clemmens B; Simmonds D; Calabro FJ; Montez DF; Lekht JA; Day NL; Richardson GA; Luna B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Aug; 3(8):713-725. PubMed ID: 30033100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.
    Sánchez-Torres AM; Basterra V; Rosa A; Fañanás L; Zarzuela A; Ibáñez B; Peralta V; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):643-53. PubMed ID: 23580110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder.
    Braga RJ; Burdick KE; Derosse P; Malhotra AK
    Psychiatry Res; 2012 Dec; 200(2-3):242-5. PubMed ID: 22818174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls.
    Lawn W; Fernandez-Vinson N; Mokrysz C; Hogg G; Lees R; Trinci K; Petrilli K; Borissova A; Ofori S; Waters S; Michór P; Wall MB; Freeman TP; Curran HV
    Psychopharmacology (Berl); 2022 May; 239(5):1629-1641. PubMed ID: 35486121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study.
    Cousijn J; Wiers RW; Ridderinkhof KR; van den Brink W; Veltman DJ; Porrino LJ; Goudriaan AE
    Addict Biol; 2013 Nov; 18(6):1013-23. PubMed ID: 22994937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study.
    Cousijn J; Wiers RW; Ridderinkhof KR; van den Brink W; Veltman DJ; Goudriaan AE
    Hum Brain Mapp; 2014 May; 35(5):2470-82. PubMed ID: 24038570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risky decision-making as an antecedent or consequence of adolescent cannabis use: findings from a 2-year longitudinal study.
    Pacheco-Colón I; Lopez-Quintero C; Coxe S; Limia JM; Pulido W; Granja K; Paula DC; Gonzalez I; Ross JM; Duperrouzel JC; Hawes SW; Gonzalez R
    Addiction; 2022 Feb; 117(2):392-410. PubMed ID: 34184776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex.
    Rigucci S; Xin L; Klauser P; Baumann PS; Alameda L; Cleusix M; Jenni R; Ferrari C; Pompili M; Gruetter R; Do KQ; Conus P
    Psychopharmacology (Berl); 2018 Jan; 235(1):13-22. PubMed ID: 29075884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marijuana Use Predicts Cognitive Performance on Tasks of Executive Function.
    Dahlgren MK; Sagar KA; Racine MT; Dreman MW; Gruber SA
    J Stud Alcohol Drugs; 2016 Mar; 77(2):298-308. PubMed ID: 26997188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response inhibition and elevated parietal-cerebellar correlations in chronic adolescent cannabis users.
    Behan B; Connolly CG; Datwani S; Doucet M; Ivanovic J; Morioka R; Stone A; Watts R; Smyth B; Garavan H
    Neuropharmacology; 2014 Sep; 84():131-7. PubMed ID: 23791961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive functions and behavioral economic demand for cannabis among young adults: Indirect associations with cannabis consumption and cannabis use disorder.
    Coelho SG; Hendershot CS; Aston ER; Ruocco AC; Quilty LC; Tyndale RF; Wardell JD
    Exp Clin Psychopharmacol; 2024 Jun; 32(3):305-315. PubMed ID: 37732960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study.
    Meier MH; Caspi A; Danese A; Fisher HL; Houts R; Arseneault L; Moffitt TE
    Addiction; 2018 Feb; 113(2):257-265. PubMed ID: 28734078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological sex differences associated with age of initiated use among young adult cannabis users.
    Crane NA; Schuster RM; Mermelstein RJ; Gonzalez R
    J Clin Exp Neuropsychol; 2015; 37(4):389-401. PubMed ID: 25832823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects.
    Smith MJ; Cobia DJ; Wang L; Alpert KI; Cronenwett WJ; Goldman MB; Mamah D; Barch DM; Breiter HC; Csernansky JG
    Schizophr Bull; 2014 Mar; 40(2):287-99. PubMed ID: 24342821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis use disorders in schizophrenia: effects on cognition and symptoms.
    DeRosse P; Kaplan A; Burdick KE; Lencz T; Malhotra AK
    Schizophr Res; 2010 Jul; 120(1-3):95-100. PubMed ID: 20483565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.